Skip to content

SCHEDULE 13G/AAccepted Apr 30, 4:06 PM ET

Quince Therapeutics, Inc. SCHEDULE 13G/A

Sofinnova Partners SAS

Accepted (ET)

4:06 PM

Apr 30, 2025

Filed

Apr 30, 2025

Documents

2

Size

30.0 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.